134 related articles for article (PubMed ID: 20163376)
1. Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.
Shiffman ML; Pockros P; McHutchison JG; Schiff ER; Morris M; Burgess G
Aliment Pharmacol Ther; 2010 May; 31(9):969-78. PubMed ID: 20163376
[TBL] [Abstract][Full Text] [Related]
2. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.
Pockros PJ; Schiff ER; Shiffman ML; McHutchison JG; Gish RG; Afdhal NH; Makhviladze M; Huyghe M; Hecht D; Oltersdorf T; Shapiro DA
Hepatology; 2007 Aug; 46(2):324-9. PubMed ID: 17654603
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
Lee MH; Kim YM; Kim SG
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
5. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
6. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C.
Nadeem A; Hussain MM; Aslam M
J Coll Physicians Surg Pak; 2010 Oct; 20(10):657-61. PubMed ID: 20943107
[TBL] [Abstract][Full Text] [Related]
8. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
9. Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.
Gordon A; Hobbs DA; Bowden DS; Bailey MJ; Mitchell J; Francis AJ; Roberts SK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):275-80. PubMed ID: 16460486
[TBL] [Abstract][Full Text] [Related]
10. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
11. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients.
Hu YH; Lin CL; Huang YW; Liu PE; Hwang DF
Amino Acids; 2008 Aug; 35(2):469-73. PubMed ID: 17690950
[TBL] [Abstract][Full Text] [Related]
12. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
[TBL] [Abstract][Full Text] [Related]
13. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.
Crosignani A; Budillon G; Cimino L; Del Vecchio Blanco C; Loguercio C; Ideo G; Raimondo G; Stabilini R; Podda M
Hepatogastroenterology; 1998; 45(23):1624-9. PubMed ID: 9840118
[TBL] [Abstract][Full Text] [Related]
14. First-in-class pan caspase inhibitor developed for the treatment of liver disease.
Linton SD; Aja T; Armstrong RA; Bai X; Chen LS; Chen N; Ching B; Contreras P; Diaz JL; Fisher CD; Fritz LC; Gladstone P; Groessl T; Gu X; Herrmann J; Hirakawa BP; Hoglen NC; Jahangiri KG; Kalish VJ; Karanewsky DS; Kodandapani L; Krebs J; McQuiston J; Meduna SP; Nalley K; Robinson ED; Sayers RO; Sebring K; Spada AP; Ternansky RJ; Tomaselli KJ; Ullman BR; Valentino KL; Weeks S; Winn D; Wu JC; Yeo P; Zhang CZ
J Med Chem; 2005 Nov; 48(22):6779-82. PubMed ID: 16250635
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
[TBL] [Abstract][Full Text] [Related]
16. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
17. Artichoke leave extract for chronic hepatitis C - a pilot study.
Huber R; Müller M; Naumann J; Schenk T; Lüdtke R
Phytomedicine; 2009 Sep; 16(9):801-4. PubMed ID: 19427774
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
[TBL] [Abstract][Full Text] [Related]
19. Randomized double blind placebo-controlled trial of a Chinese herbal therapy (CH100) in chronic hepatitis C.
Mollison L; Totten L; Flexman J; Beaman M; Batey R
J Gastroenterol Hepatol; 2006 Jul; 21(7):1184-8. PubMed ID: 16824073
[TBL] [Abstract][Full Text] [Related]
20. Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study.
Reesink HW; Zeuzem S; Weegink CJ; Forestier N; van Vliet A; van de Wetering de Rooij J; McNair L; Purdy S; Kauffman R; Alam J; Jansen PL
Gastroenterology; 2006 Oct; 131(4):997-1002. PubMed ID: 17030169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]